Potential GM-CSF contribution to RA involves augmentation of macrophage polarization to the M1 type, induction of proinflammatory response in CD4+ T, Th17, stromal cells, and ILCs, boosting up IL-1β, IL-6, IL-17, IL-23 production [129,130]. The gene discussed is CSF2; the disease is rheumatoid arthritis.